1-(2,4-Difluorophenyl)-4-iodo-1H-pyrazolo[3,4-b]pyridine

Catalog No. :
ACVWFM770
CAS No. :
1356054-70-0
Molecular Formula :
C12H6F2IN3
Molecular Weight :
357.10

IUPAC Name:1-(2,4-difluorophenyl)-4-iodo-1H-pyrazolo[3,4-b]pyridine

1-(2,4-Difluorophenyl)-4-iodo-1H-pyrazolo[3,4-b]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$779.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(2,4-Difluorophenyl)-4-iodo-1H-pyrazolo[3,4-b]pyridine
IUPAC Name1-(2,4-difluorophenyl)-4-iodo-1H-pyrazolo[3,4-b]pyridine
MDL No.MFCD21607382
Molecular FormulaC12H6F2IN3
Molecular Weight357.10
SMILESIC1=C2C(N(C3=CC=C(F)C=C3F)N=C2)=NC=C1
InChI KeyGOCYTLKWXZZAGL-UHFFFAOYSA-N
Synonym1-(2,4-DIFLUOROPHENYL)-4-IODO-1H-PYRAZOLO[3,4-B]PYRIDINE;1H-Pyrazolo[3,4-b]pyridine, 1-(2,4-difluorophenyl)-4-iodo-
CAS No.1356054-70-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACVWFM770 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXBKV471 route compound structure diagram
    ACXBKV47151523-79-6 In Stock
  2. Plus
  3. ACSVCH687 route compound structure diagram
    ACSVCH687153034-82-3 In Stock
  4. Then
  5. ACVWFM770 route product structure diagram
    ACVWFM7701356054-70-0
Inquiry

2. ACVWFM770 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXBKV471 route compound structure diagram
    ACXBKV47151523-79-6 In Stock
  4. Plus
  5. ACSVCH687 route compound structure diagram
    ACSVCH687153034-82-3 In Stock
  6. Then
  7. ACVWFM770 route product structure diagram
    ACVWFM7701356054-70-0
Inquiry

Comments (0)